Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study is a biphasic steady state pharmacokinetic and pharmacodynamic study of TFV and
FTC in healthy women comparing the drug levels and activity in the absence (first phase) and
then the presence (second phase) of DMPA. The investigators will recruit 12 healthy women
aged 18-45 who are HIV-negative and at low risk for acquiring HIV.